NEN-EN-ISO 18562-1
Biocompatibility evaluation of breathing gas pathways in healthcare applications - Part 1: Evaluation and testing within a risk management process
| Organization: | NEN |
| Publication Date: | 1 March 2020 |
| Status: | active |
| Page Count: | 38 |
| ICS Code (Anaesthetic, respiratory and reanimation equipment): | 11.040.10 |
scope:
This document specifies:
- the general principles governing the biological evaluation within a RISK MANAGEMENT PR
- the general categorization of GAS PATHWAYS based on the nature and duration of their contact with the gas stream;
- the evaluation of existing relevant data from all sources;
- the identification of gaps in the available data set on the basis of a RISK ANALYSIS;
- the identification of additional data sets necessary to analyse the biological safety of the GAS PATHWAYS;
- the assessment of the biological safety of the GAS pathways.
This document covers general principles regarding BIOCOMPATI
This document addresses potential contamination of the gas stream arising from the GAS PATHWAYS within the MEDICAL DEVICE, which might then be conducted to the PATIENT.
This document applies over the EXPECTED SERVICE
This document does not address biological evaluation of the surfaces of MEDICAL DEVICES that are in direct contact with the PATIENT. The requirements for direct contact surfaces are found in the ISO 10993 series.
MEDICAL DEVICES, parts or ACCESSORIES containing GAS PATHW
This document does not address contamination already present in the gas supplied from the gas sources while MEDICAL DEVICE
EXAMPLE Contamination arriving at the MEDICAL DEVICE from gas sources such as MEDICAL GAS PIPEL
Future parts might be added to address other relevant aspects of biological testing including additional contamination that might arise from the GAS PATHWAY because of the presence of drugs and anaesthetic agents added to the gas stream.
NOTE 1 Some AUTHORITIES HAV
NOTE 2 This document has been prepared to address the relevant essential principles of safety and performance as indicated in Annex B.
Document History